Chlorothiazide Sodium Injection, Powder, Lyophilized, For Solution
Product Images NDC 47335-330

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Chlorothiazide Sodium (NDC 47335-330). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chlorothiazide-sodium-structure (Chlorothiazide Na St)

Chemical structure diagram of Chlorothiazide Sodium, showing its molecular components including sulfonamide, chlorine, sodium, and the heterocyclic ring.*

FDA Label Image

Chlorothiazide-carton (Chlorothiazide Carton)

Packaging label for Chlorothiazide Sodium for Injection, USP 500 mg/vial, sterile lyophilized powder by Sun Pharmaceutical Industries, Inc. Designed for intravenous solution preparation, the label includes dosage information, inactive ingredients, storage instructions, and a barcode. Distributed by Sun Pharmaceutical Industries, Inc., the label emphasizes single-dose vial usage and reconstitution details.*

FDA Label Image

Chlorothiazide-structure (Chlorothiazide Str)

Chemical structure of Chlorothiazide Sodium showing its molecular arrangement including chlorine, sulfonamide, and other functional groups as depicted in the diagram.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.